首页>
外国专利>
RECOMBINANT ENDOTHELIAL CELL GROWTH INHIBITORS DERIVED FROM A MAMMALIAN PLASMINOGEN
RECOMBINANT ENDOTHELIAL CELL GROWTH INHIBITORS DERIVED FROM A MAMMALIAN PLASMINOGEN
展开▼
机译:哺乳动物纤溶酶原来源的重组内皮细胞生长抑制剂
展开▼
页面导航
摘要
著录项
相似文献
摘要
Proteolytic enzymes are involved in generation of a number of endogenous angiogenesis inhibitors and it has been shown that urokinase-activated plasmin can process plasminogen to release an angiogenesis inhibitor, K1-5 (protease-activated kringles 1-5). However, this proteolytic protein (proteolytic K1-5) cannot be secreted (exported) from cells and thus is limited in its application as a therapeutic. The present inventor has now engineered a recombinant protein derived from plasminogen which is folded correctly such that it can be secreted from cells in which it is expressed. The inventor surprisingly found that in order to fold correctly such that it can be secreted, the recombinant protein must comprise a secretory signal peptide and a pre-activation peptide derived from plasminogen.
展开▼